Orchid Pharma Ltd
NSE:ORCHPHARMA

Watchlist Manager
Orchid Pharma Ltd Logo
Orchid Pharma Ltd
NSE:ORCHPHARMA
Watchlist
Price: 776.1 INR -0.13% Market Closed
Market Cap: 39.4B INR

During the last 3 months Orchid Pharma Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 57% over this period (open performance analysis).

The last transaction was made on Jan 24, 2022 by M/S Dhanuka Laboratories Limited (Director) , who bought 3.1B INR worth of ORCHPHARMA shares.

Last Transactions:
M/S Dhanuka Laboratories Limited
Director
₹+3.1B
M/S Dhanuka Laboratories Limited
Director
₹+5B
M/S Dhanuka Laboratories Limited
Director
₹+11B
M/S Dhanuka Laboratories Limited
Director
₹-1.6B
View All Transactions

During the last 3 months Orchid Pharma Ltd insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 57% over this period (open performance analysis).

The last transaction was made on Jan 24, 2022 by M/S Dhanuka Laboratories Limited (Director) , who bought 3.1B INR worth of ORCHPHARMA shares.

Sold
0-3
months
0 INR
0
3-6
months
0 INR
0
6-9
months
0 INR
0
9-12
months
0 INR
0
Bought
0-3
months
No Insider Transactions
0
0 INR
3-6
months
No Insider Transactions
0
0 INR
6-9
months
No Insider Transactions
0
0 INR
9-12
months
No Insider Transactions
0
0 INR

Orchid Pharma Ltd
Insider Trading Chart

Orchid Pharma Ltd
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Orchid Pharma Ltd
Last Insider Transactions

Global
Insiders Monitor

Orchid Pharma Ltd
Glance View

Market Cap
39.4B INR
Industry
Pharmaceuticals

Orchid Pharma Ltd. engages in the development, manufacture, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company is headquartered in Chennai, Tamil Nadu. The firm is involved in the development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals. The company has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. The company offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, Veterinary Products and Non-Antibodies. Its formulations include Cefixime Capsules, Acarbose Tablets, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Europe Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc., and Diakron Pharmaceuticals, Inc., among others.

ORCHPHARMA Intrinsic Value
1 177.64 INR
Undervaluation 34%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top